BridgeMD
Prevention study for Contrast-induced Acute Kidney Injury (CI-AKI) Following Coronary Angiogram...
Official title Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.
ClinicalTrials.gov ID: NCT05147831
What this study is testing
- What it's testing
- The use of imaging is increasing in clinical practice, either for diagnosis or intervention. In these imaging processes, contrast medium (CM) is widely used.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- (1) Patients undergoing an treatment or diagnostic radiological procedure in which they receive intravascular contrast, including patients undergoing...
- (2) patients presenting with a renal clearance in the range of less than 60 ml/min/1.73 m2 but not declared ESRD
- (3) Patients who are not yet recruited for other pharmacological or medical device clinical trials.
You likely can't join if
- (1) Age \<18 years
- (2) Patient on hemodialysis or peritoneal dialysis
- (3) Simultaneous participation in another treatment study
- (4) Percutaneous coiling/embolization procedures of the kidney
- (5) Impossibility to perform RIPC, caused by pathology in both arms (e.g. dystrophy, recent trauma, chronic wounds)
- (6) No written informed consent
See the full eligibility criteria
- (1) Patients undergoing an treatment or diagnostic radiological procedure in which they receive intravascular contrast, including patients undergoing coronary angiogram +/- percutaneous coronary intervention (PCI) for...
- (2) patients presenting with a renal clearance in the range of less than 60 ml/min/1.73 m2 but not declared ESRD
- (3) Patients who are not yet recruited for other pharmacological or medical device clinical trials.
- (1) Age \<18 years
- (2) Patient on hemodialysis or peritoneal dialysis
- (3) Simultaneous participation in another treatment study
- (4) Percutaneous coiling/embolization procedures of the kidney
- (5) Impossibility to perform RIPC, caused by pathology in both arms (e.g. dystrophy, recent trauma, chronic wounds)
- (6) No written informed consent
- (7) Urgent angiography in STEMI
- (8) Cardiogenic shock requiring catecholamine infusion
- (9) Systolic blood pressure \<80 mmHg
- (10) Intra-aortic balloon counter-pulsation
- (11) Contrast medium injection within the previous 30 days
- (12) Expected impossibility to obtain follow-up data at 6-week follow-up
- (13) Patients with Raynaud's disease
The study team makes the final eligibility decision.
Where it's taking place
- Galveston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Galveston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.